Adjuvant Capecitabine In Triple Negative Breast Cancer: The Earlier, The Better?

J Oncol Pharm Pract. 2022 Jan;28(1):203-204. doi: 10.1177/10781552211045909. Epub 2021 Oct 9.

Authors

D C Guven¹, H Taban¹, O Dizdar¹

Affiliation

¹ 64005Hacettepe University Cancer Institute, Department of Medical Oncology, Ankara, Turkey.

PMID: 34628993
DOI: 10.1177/10781552211045909

No abstract available

Keywords: adjuvant; capecitabine; triple negative breast cancer.

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Breast Neoplasms* / drug therapy
Capecitabine / adverse effects
Chemotherapy, Adjuvant
Female
Humans
Neoadjuvant Therapy
Triple Negative Breast Neoplasms* / drug therapy

Substances

Capecitabine